SPTAN1 and colorectal neoplasm: Given that the predicted effects of SPTAN1 expression levels on tumour biology did not fully explain why SPTAN1-high colorectal tumours have better survival outcomes, we considered whether the observed survival advantage may result from a favourable response to FOLFOX chemotherapy in the SPTAN1-high group.